Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCOMMENTARY

Container–Content Compatibility Studies: A Pharmaceutical Team's Integrated Approach

Alda Laschi, Natacha Sehnal, Antoine Alarcon, Beatrice Barcelo, François Caire-Maurisier, Myriam Delaire, Marc Feuilloley, Stéphanie Genot, Catherine Lacaze, Luc Pisarik and Christophe Smati
PDA Journal of Pharmaceutical Science and Technology July 2009, 63 (4) 285-293;
Alda Laschi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Alda.Laschi@sanofipasteur.com
Natacha Sehnal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Alarcon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatrice Barcelo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Caire-Maurisier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myriam Delaire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Feuilloley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphanie Genot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Lacaze
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luc Pisarik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Smati
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    European Medicines Agency. CPMP/QWP/4359/03, EMEA/CVMP/205/04: Guideline on Plastic Immediate Packaging Materials. European Medicines Agency: London, UK, 19 May 2005
  2. 2.↵
    European Pharmacopoeia, 6th ed.; 2008, 6.1: 3.1.3 Polyolefins; 3.1.4. & 3.1.5 Polyethylene without and with additives for containers for parenteral preparations and for ophthalmic preparations; 3.1.6 Polypropylene for containers and closures for parenteral and ophthalmic preparations; 3.1.7 Polyethylene-vinyl acetate for containers and tubing for parenteral nutrition preparations; 3.2.1 Glass containers for pharmaceutical use; 3.2.2 to 3.2.8 Plastic containers … ; 3.2.9 Rubber closures for containers for aqueous parenteral preparations for powder and for freeze-dried products
  3. 3.↵
    Food and Drug Administration. Guidance for Industry—Container–Closure Systems for Packaging Human Drugs and Biologics, 1999.
  4. 4.↵
    Food and Drug Administration. Guidance for Industry—Nasal Spray and Inhalation Solution, Suspension and Drug Products Points To Consider, 2002.
  5. 5.↵
    Code of Federal Regulations. 21 CFR 211.94(a) through Subpart E: Control of Components and Drug Product Containers and Closures.
  6. 6.↵
    Code of Federal Regulations. 21 CFR 310.509: Requirements for specific new drugs or devices—parenteral drug products in plastic containers.
  7. 7.↵
    Code of Federal Regulations. 21 CFR 600.11: Biological products—(b) Equipment through (h) Containers & closures.
  8. 8.↵
    United States Pharmacopoeia 30, 2007: 〈1031〉 Biocompatibility of materials used in drug containers, medical devices and implants, pp 402–410: 〈87〉 Biological reactivity tests, in vitro, pp 113–115; 〈88〉 Biological reactivity tests, in vivo, pp 115–118; (661) Containers, pp 260–267; (381) Elastomeric closure for injections, pp 157–158; 〈671〉 Containers permeation, pp 267–269
  9. 9.↵
    Japanese Pharmacopoeia XV, 2006: 〈11〉 Plastic container for pharmaceutical products; 〈59〉 Tests for rubber closures for aqueous infusions; 〈61〉 Tests methods for plastic containers, 7 cytotoxicity tests
  10. 10.↵
    ISO Standard 10993 Biological Evaluation of Medical Devices. Part 1: Evaluation and Testing
  11. 11.↵
    PQRI. Reporting and Qualification Thresholds for Leachables in Parenteral and Ophthalmic Drug Products, March 2007
  12. 12.↵
    PQRI. Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products, September 2006.
  13. 13.↵
    American Society for Testing and Materials F813-01. Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices.
  14. 14.↵
    American Society for Testing and Materials F895. Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity.
  15. 15.↵
    International Conference on Harmonization. ICH Q2 (R1): Validation of Analytical Procedures: Text and Methodology, 2005.
  16. 16.↵
    International Conference on Harmonization. ICH Q3B (R2): Impurities in New Drug Products, 2006.
  17. 17.↵
    International Conference on Harmonization. ICH Q1A (R2): Stability Testing Guidelines: Stability Testing of New Drug Substances and Products (CPMP/ICH/380/95—2nd revision 2003).
  18. 18.↵
    International Conference on Harmonization. ICH Q5C: Stability Testing of Biotechnological/Biological Products (CPMP/ICH/138/95—revision 1999).
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology
Vol. 63, Issue 4
July/August 2009
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Container–Content Compatibility Studies: A Pharmaceutical Team's Integrated Approach
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Container–Content Compatibility Studies: A Pharmaceutical Team's Integrated Approach
Alda Laschi, Natacha Sehnal, Antoine Alarcon, Beatrice Barcelo, François Caire-Maurisier, Myriam Delaire, Marc Feuilloley, Stéphanie Genot, Catherine Lacaze, Luc Pisarik, Christophe Smati
PDA Journal of Pharmaceutical Science and Technology Jul 2009, 63 (4) 285-293;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Container–Content Compatibility Studies: A Pharmaceutical Team's Integrated Approach
Alda Laschi, Natacha Sehnal, Antoine Alarcon, Beatrice Barcelo, François Caire-Maurisier, Myriam Delaire, Marc Feuilloley, Stéphanie Genot, Catherine Lacaze, Luc Pisarik, Christophe Smati
PDA Journal of Pharmaceutical Science and Technology Jul 2009, 63 (4) 285-293;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Regulatory Publications
    • Migration Phenomena Evalutation
    • Toxicological Aspects
    • Decision Trees
    • Extractables Study
    • Leachables Study
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products
  • Google Scholar

More in this TOC Section

  • Chemical and Process Parameters Influencing Gelling during Pharmaceutical Wet Media Milling
  • Challenges Encountered in the Implementation of Bio-Fluorescent Particle Counting Systems as a Routine Microbial Monitoring Tool
  • Parametric Release of Moist Heat Sterilized Products: History and Current State
Show more Commentary

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire